Implementing AI to help track, analyze, simulate, and predict population-level disease outcomes

Global health challenges cannot be solved without better data. Airfinity tracks, predicts and simulates population level disease outcomes in real time to inform decisions that can increase the global life span.

Multiple industries have relied on forecasting for decades. We believe it’s time for the pharmaceutical industry to catch up by providing tailored intelligence solutions built on proprietary technology, data and expert analysts.

Airfinity uses a unique quantitative approach that combines advanced meta science and statistics, large language models, epidemiology, and dynamic machine learning solutions to understand true disease prevalence and underlying outcome drivers as they evolve. 

By building AI and large-scale simulation model forecasts focusing on the predictive indicators that could significantly impact disease burden, we can help provide a more nuanced and holistic view of the changing landscape, including any ‘blind spots’ your organization or the industry might have. 

Airfinity is continuously refining its models, diversifying its data sets, and expanding its disease coverage to ensure our team produces the highest quality intelligence and predictions. 

Schedule a free session with our quant analysts to better understand how Airfinity deploys these different technologies within your disease or therapy area of focus. 

Get in touch to find out more

Fill in the below form and a member of the team will be in touch.

Get in touch to find out more

Fill in the below form and a member of the team will be in touch.

Analysis & Insights

The West should be on a war footing for the next pandemic
The West should be on a war footing for the next pandemic

The COVID-19 pandemic is not a once in a lifetime risk, the next deadly virus could emerge sooner than we think. Western allies need to be prepared and should be on a constant war footing for the next outbreak.

Read More →


More from Airfinity

Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity

From resistance to resilience: what could the future antibiotic pipeline look like?

Airfinity further expands into APAC with launch of Japan office

Stockpiles worth $1.1 billion of COVID-19 antiviral pill Paxlovid have expired in UK and Europe

Airfinity Named The Financial Times' Healthcare Tech Champion 2023

Airfinity upgrades global biorisk platform

Airfinity named among Bloomberg’s UK Startups to Watch 2023

View All →

In the News

New Covid FLiRT Variants Have the FDA Weighing a Vaccine Update

Bloomberg | May 23, 2024

The West should be on a war footing for the next pandemic

The Telegraph | May 22, 2024

The HIV response beyond 2030: preparing for decades of sustained HIV epidemic control in eastern and southern Africa

The Lancet | May 20, 2024

Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity

AP News | May 15, 2024

View All →